Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,948.00    4.00 (0.08%)
Bid:
4,956.00
Ask:
4,964.00
Spread: 8.00 (0.161%)
Market Cap: £2.31b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Pre-close trading update

17 Dec 2009 07:00

RNS Number : 2597E
Morgan Sindall PLC
17 December 2009
 



17 Dec 2009

Morgan Sindall plc

Morgan Sindall plc, the construction and regeneration group, provides the following period end trading update in advance of the announcement of its preliminary results for the year ended 31 December 2009, expected to be in late February 2010. 

Trading

As previously announced in our Interim Management Statement on 10 November, Morgan Sindall remains on track to achieve its expectations for the current year, despite the challenging market conditions in which it is operating. 

Fit Out is performing strongly in tough market conditions with margins remaining robust and it continues to see a recovery in the level of tendering activity.

Construction is still experiencing healthy demand from the public sector and, in particular, is currently advancing two major projects at preferred bidder stage, Tayside Mental Health (£100m) and Hull BSF (£200m). We expect to achieve financial close on these projects during the first quarter of 2010. There remains considerable uncertainty over future public spending commitments.

Infrastructure Services continues to perform well in reasonably buoyant market conditions and the division continues to progress a number of major opportunities. Although the bidding processes are proving more protracted than initially anticipated, we continue to await the outcome of preferred bidder decisions on a number of contracts. 

Affordable Housing is still seeing a reasonable pipeline of refurbishment and new build social housing opportunities. This is complemented by improvements in demand for open market housing with sales continuing to improve.

Urban Regeneration's market remains subdued although we expect recovery in market conditions in the longer term.

The Investments division is seeing a strong pipeline of opportunities and we expect that it will increase its level of bidding activity in 2010, thereby taking advantage of the Group's increasing ability to deliver larger and more complex projects since the acquisition made in 2007.

Outlook

The Group's forward order book has reduced from £3.6bn to £3.2bn since 30 June 2009. However, this forward order book is supplemented by over £900m of projects at preferred bidder stage, all of which have been awarded during the second half of this year. 

We remain mindful of the challenges facing the sector in the longer term and continue to shape our business accordingly. Each of our divisions continues to particularly focus on cash management, cost reduction and supply chain improvements, as well as responding to market growth opportunities where they present themselves.

In summary, Morgan Sindall is on track to meet our expectations for 2009 and is well placed to meet the challenges and opportunities in 2010.

Enquiries:

Morgan Sindall plc

Tel: 020 7307 9200

Paul Smith, Chief Executive

David Mulligan, Finance Director

Blythe Weigh Communications

Tel: 020 7138 3204 

Tim Blythe

Mob: 07816 924626

Paul Weigh

Mob: 07989 129658 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTCKAKBOBDDNBD
Date   Source Headline
2nd Jan 20208:30 amRNSTotal Voting Rights
21st Nov 20199:21 amRNSDirector/PDMR Shareholding
20th Nov 201911:43 amRNSAdditional Listing
18th Nov 20199:48 amRNSAppointment to c£650m Slough scheme
18th Nov 20197:00 amRNSSenior Management Forum
11th Nov 201912:05 pmRNSHolding(s) in Company
11th Nov 201910:25 amRNSDirector/PDMR Shareholding
6th Nov 20197:00 amRNSTrading Update
1st Nov 20191:58 pmRNSTotal Voting Rights
21st Oct 201910:07 amRNSBlock listing Interim Review
8th Oct 20194:37 pmRNSPrice Monitoring Extension
2nd Oct 20194:08 pmRNSHolding(s) in Company
1st Oct 201910:19 amRNSTotal Voting Rights
3rd Sep 201911:30 amRNSAdditional Listing
2nd Sep 20192:49 pmRNSTotal Voting Rights
13th Aug 20193:34 pmRNSHolding(s) in Company
7th Aug 20197:00 amRNSHalf-year Report
1st Aug 201910:08 amRNSTotal Voting Rights
30th Jul 20194:44 pmRNSHolding(s) in Company
9th Jul 20197:00 amRNSNotice of Results
1st Jul 201910:20 amRNSTotal Voting Rights
24th Jun 20194:05 pmRNSHolding(s) in Company
31st May 20193:13 pmRNSHolding(s) in Company
31st May 20199:33 amRNSTotal Voting Rights
22nd May 20199:23 amRNSDirector Declaration
16th May 20198:30 amRNSAdditional Listing
9th May 201910:11 amRNSAwarded £1.6bn Sellafield contract
8th May 201912:21 pmRNSResult of AGM
8th May 20197:00 amRNSAGM Trading Update
1st May 201912:26 pmRNSTotal Voting Rights
23rd Apr 201912:05 pmRNSBlock listing Interim Review
1st Apr 201910:03 amRNSTotal Voting Rights
22nd Mar 20197:00 amRNSMorgan Sindall Group announces £1bn joint venture
21st Mar 201911:38 amRNSAnnual Financial Report
14th Mar 20193:36 pmRNSAdditional Listing - Amendment
14th Mar 20198:00 amRNSAdditional Listing
5th Mar 20194:03 pmRNSHolding(s) in Company
4th Mar 20193:19 pmRNSDirector/PDMR Shareholding
4th Mar 20193:13 pmRNSDirector/PDMR Shareholding
4th Mar 20193:10 pmRNSDirector/PDMR Shareholding
1st Mar 20191:58 pmRNSTotal Voting Rights
21st Feb 20197:00 amRNSFinal Results
1st Feb 201910:28 amRNSTotal Voting Rights
10th Jan 20193:37 pmRNSHolding(s) in Company
9th Jan 20197:00 amRNSNotice of Results
3rd Jan 20192:04 pmRNSTotal Voting Rights
19th Dec 201810:54 amRNSDirector Declaration
3rd Dec 20184:37 pmRNSTotal Voting Rights
20th Nov 20187:00 amRNSSenior Management Forum
16th Nov 20182:53 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.